Showing results (71-80 of 284) with videos related to
Sort By:
Pageof 29
American Journal of Human Genetics|July 1, 1996
A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2qG T Fouad, S Servidei, S Durcan, et al.Neuromuscular Disorders : NMD|March 16, 2013
A new de novo missense mutation in MYH2 expands clinical and genetic findings in hereditary myosin myopathiesA D'Amico, F Fattori, E Bellacchio, et al.Electroencephalography and Clinical Neurophysiology|September 1, 1995
Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study)C Munari, P Kahane, S Francione, et al.Neuroscience|September 27, 2005
Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle painM Valeriani, D Le Pera, D Restuccia, et al.Nature|May 25, 1989
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop regionM Zeviani, S Servidei, C Gellera, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1992
Bilateral striatal necrosis, dystonia and optic atrophy in two siblingsV Leuzzi, E Bertini, A M De Negri, et al.Acta Neuropathologica|January 1, 1992
Giant axonal neuropathy: report on a case with focal fiber lossM Sabatelli, E Bertini, S Servidei, et al.American Journal of Obstetrics and Gynecology|January 1, 1989
Reduced serum inhibition of platelet-activating factor activity in preeclampsiaC Benedetto, M Massobrio, E Bertini, et al.Human Mutation|October 23, 2001
Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndromeS Salvi, C Dionisi-Vici, E Bertini, et al.Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.Pageof 29